Caffeine-induced sleep disorder
|Caffeine-induced sleep disorder|
|Classification and external resources|
Caffeine-induced sleep disorder is a psychiatric disorder that results from overconsumption of the stimulant caffeine. “When caffeine is consumed immediately before bedtime or continuously throughout the day, sleep onset may be delayed, total sleep time reduced, normal stages of sleep altered, and the quality of sleep decreased.” Caffeine reduces slow-wave sleep in the early part of the sleep cycle and can reduce rapid eye movement sleep later in the cycle. Caffeine increases episodes of wakefulness, and high doses in the late evening can increase sleep onset latency. In elderly people, there is an association between use of medication containing caffeine and difficulty in falling asleep.
The specific criteria for this disorder in the fourth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) include that there must be a significant inability to sleep which is caused entirely by the physiological effects of caffeine as proven by an examination; if sleeping issues can be accounted for due to a breathing-related sleep disorder, narcolepsy, a circadian rhythm sleep disorder or a mental disorder, then caffeine-induced sleep disorder is not the cause. This condition causes a notable impairment in functioning in sufferers.
Although the maximum daily consumption of caffeine varies with consideration of couple of aspects such as gender, age, race, physical activity and smoking, excessive ingestion of caffeine can lead to a state of intoxication. This period of intoxication is characterized by restlessness, agitation, excitement, rambling thought or speech, and even insomnia. Even doses of caffeine relating to just one cup of coffee can increase sleep latency and decrease the quality of sleep especially in non-REM deep sleep. A dose of caffeine taken in the morning can have these effects the following night, so one of the main practices of sleep hygiene a person can do is to cease the consumption of caffeine.
Mechanism of caffeine
Caffeine enters the bloodstream through the stomach and small intestine and can have a stimulating effect as soon as 15 minutes after consumption. Once it is in the body, caffeine will persist for several hours, and takes about six hours for one half of the caffeine consumed to be eliminated. When caffeine reaches the brain, it increases the secretion of norepinephrine which is related to the “fight or flight” response. The rise in norepinephrine levels increases activity of neurons in areas of the brain and the symptoms resemble those of a panic attack.
Though caffeine can be shown to decrease the quality of sleep, there is no evidence that caffeine affects all people the same way. In fact, some people report no sleep problems despite regularly consuming caffeine. Regular intake of caffeine may be normal for a person so it is understandable how they may still get satisfactory sleep. This finding shows that caffeine interferes with a modulatory mechanism in sleep regulation rather than a fundamental sleep regulatory brain circuit. Ultimately, regular sleep habits are important in overall quality and timing of sleep.
- “Sleep and Caffeine” (PDF). Johns Hopkins University School of Medicine. Retrieved 2 November 2015.
- “Neuropsychiatric effects of caffeine”. Anthony P. Winston, Elizabeth Hardwick, Neema Jaberi. Retrieved 2 November 2015.
- R. Gregory Lande (2005-07-07). “Caffeine-Related Psychiatric Disorders”. eMedicine. Retrieved 2007-05-05.
- Tucker, Larry. “Caffeine Consumption and Telomere Length in Men and Women of the National Health and Nutrition Examination Survey (NHANES)”.
- Olini, N.; Kurth, S.; Huber, R. (2013). “The Effects of Caffeine on Sleep and Maturational Markers in the Rat”. PLoS ONE. 8 (9): e72539. doi:10.1371/journal.pone.0072539. PMC 3762801. PMID 24023748.
- “Sleep and Caffeine”.
- “Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use”.
- Broderick P, Benjamin AB (December 2004). “Caffeine and psychiatric symptoms: a review”. J Okla State Med Assoc. 97 (12): 538–42. PMID 15732884.